Skip to Main Content

Paper Details

Prognostic Value of Preoperative Molecular Testing and Implications for Initial Surgical Management in Thyroid Nodules Harboring Suspected (Bethesda V) or Known (Bethesda VI) Papillary Thyroid Cancer.
JAMA Otolaryngol Head Neck Surg
2
2023
BRAF, BRAF V600E, Bethesda, CRC, Cancer, Papillary Thyroid Cancer, RAI, RAS, TERT, TERT mutation, ThyroSeq, ThyroSeq CRC alterations, V600E, cancer, differentiated thyroid cancer, papillary thyroid cancer, patient, patients, thyroid cancer, thyroid nodules, thyroidectomy
Author NameAffiliation
Chi-Hong Tsenguniversity of california los angeles David Geffen School of Medicine
Chi-Hong Tsenguniversity of california los angeles David Geffen School of Medicine
Dipti P Sajeduniversity of california los angeles David Geffen School of Medicine
  • 1 - 3

Datasets

Release 1.2